Antiretroviral therapy (ART) has dramatically increased the health and life expectancy of HIV-infected individuals, suppressing virus replication in the host immune cells and stopping disease pr…
As our state economy faces a long slog back to recovery from the COVID-19 pandemic, Wistar is poised to assist with the development of the workforce that will help enable that recovery. The Inst…
Creating a new drug from scratch takes many years and billions of dollars. While discovery of new molecules against SARS-CoV-2 and other emerging viruses is imperative, the world also needs solutions…
Dr. Maureen Murphy, Ira Brind Professor and program leader of the Molecular & Cellular Oncogenesis Program of The Wistar Institute Cancer Center, has been investigating the importance of inherite…
The effects of COVID-19 have dramatically changed the way we live, learn and work. While many things have come to a standstill, Wistar research has never stopped and even new educational project…
Despite an unprecedented volume of research, there are still many unanswered questions on COVID-19, especially regarding the extremely varied clinical course the disease takes, ranging from asymptoma…
Research assistant professor Ami Patel has spent her career committed to using novel engineering approaches to fight harmful infectious diseases. Her work focuses on developing next generation vaccin…
In mere weeks, philanthropic support of Wistar’s Coronavirus Discovery Fund has exceeded $1.6M in new funding thanks to an extraordinary response from individuals, foundations, and corporat…
Dr. Ertl is a global leader in Wistar’s Vaccine & Immunotherapy Center whose research focuses on preventing rabies, HBV, HIV, HPV, influenza, and other deadly viruses using innovative patented te…
The Pennsylvania Cancer Alliance, a coalition of the state’s leading cancer research institutions, meets every year in early May for a lobbying initiative to engage legislators and spotlight the impa…
